LM, H., S, M., AR, R., & NS, F. (2024). Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer. Microbial biotechnology, 17(5), e14461. https://doi.org/10.1111/1751-7915.14461
Chicago Style (17th ed.) CitationLM, Howell, Manole S, Reitter AR, and Forbes NS. "Controlled Production of Lipopolysaccharides Increases Immune Activation in Salmonella Treatments of Cancer." Microbial Biotechnology 17, no. 5 (2024): e14461. https://doi.org/10.1111/1751-7915.14461.
MLA (9th ed.) CitationLM, Howell, et al. "Controlled Production of Lipopolysaccharides Increases Immune Activation in Salmonella Treatments of Cancer." Microbial Biotechnology, vol. 17, no. 5, 2024, p. e14461, https://doi.org/10.1111/1751-7915.14461.